Toric Contact Lens Digital Performance and Comfort Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04772560 |
|
Recruitment Status :
Completed
First Posted : February 26, 2021
Results First Posted : March 10, 2022
Last Update Posted : March 10, 2022
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Astigmatism | Device: Precision1 for Astigmatism Device: Precision1 Sphere | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Toric Contact Lens Digital Performance and Comfort Study |
| Actual Study Start Date : | March 16, 2021 |
| Actual Primary Completion Date : | December 13, 2021 |
| Actual Study Completion Date : | December 13, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Toric, Then Sphere
Participants who received Toric contact lenses first and spherical lenses after 10 days
|
Device: Precision1 for Astigmatism
Daily disposable soft toric contact lens Device: Precision1 Sphere Daily disposable soft spherical contact lens |
|
Experimental: Sphere, Then Toric
Participants who received Spherical contact lenses first and Toric lenses after 10 days
|
Device: Precision1 for Astigmatism
Daily disposable soft toric contact lens Device: Precision1 Sphere Daily disposable soft spherical contact lens |
- Near Visual LogMAR Acuity [ Time Frame: 10 +/- 2 days ]High contrast LogMAR visual acuity was assessed at 40 cm using the M&S Clinical Trial Suite system (Niles, Illinois, USA). The system was calibrated according to the manufacturer's directions every day, prior to use. Testing was performed binocularly 10+/-2 days after each intervention. The test started at 20/60 and continued until three letters were missed on a line.
- Dynamic Visual Acuity [ Time Frame: 10 +/- 2 days ]Dynamic VA was determined using a custom-made iPad application. The subject was instructed to hold the iPad at 40cm and presented with a Landolt C surrounded by crowding bars for 0.3s each, starting from 0.5 LogMAR and progressing to smaller sizes using a staircase threshold method. Testing was performed binocularly 10+/-2 days after each intervention
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 39 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18 to 39 years of age (inclusive)
- pl to -6.00D vertexed sphere power and -0.75 to -1.50D vertexed refractive cylinder OD and OS
- Current/established full time (>6 days week, >8 hours/day) soft contact lens wearer
- Best corrected acuity of 20/25 or better in each eye
- Self-report of at least 4 hrs/day using digital devices
- Willing to wear lenses at least 8 hours each day during the study period
- Able to speak and read English at a high school level / have at least a high school diploma or equivalent (by self-report)
Enclusion Criteria:
- History of ocular pathology or surgery
- Binocular vision disorder (i.e., tropia, convergence or accommodative insufficiency)
- Gas permeable lens wear for at least 3 months
- Symptomatic soft contact lens wearer (CLDEQ-8 score <12 at baseline)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04772560
| United States, Texas | |
| University of Houston College of Optometry | |
| Houston, Texas, United States, 77204 | |
| Principal Investigator: | Kathryn Richdale | University of Houston College of Optometry |
Documents provided by Kathryn Richdale, University of Houston:
| Responsible Party: | Kathryn Richdale, Associate professor, University of Houston |
| ClinicalTrials.gov Identifier: | NCT04772560 |
| Other Study ID Numbers: |
STUDY00002753 |
| First Posted: | February 26, 2021 Key Record Dates |
| Results First Posted: | March 10, 2022 |
| Last Update Posted: | March 10, 2022 |
| Last Verified: | February 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
Astigmatism Refractive Errors Eye Diseases |

